Stable closure of acute and chronic wounds and pressure ulcers and control of draining fistulas from osteomyelitis in persons with spinal cord injuries: non-interventional study of MPPT passive immunotherapy delivered via telemedicine in community care
Frontiers in Medicine, 2024 · DOI: 10.3389/fmed.2023.1279100 · Published: January 5, 2024
Simple Explanation
Micropore particle technology (MPPT) is a topical treatment that supports the immune system to manage wound infections and promote tissue regeneration without using antimicrobials. This study aimed to confirm that MPPT is also effective in immunocompromised individuals, specifically people with spinal cord injuries (SCI), who typically have reduced immune cell recruitment to injuries. The study found that MPPT effectively closed various types of wounds and controlled soft tissue infections in SCI patients, leading to cost savings and reduced reliance on antimicrobials and extensive nursing care.
Key Findings
- 1All acute and chronic grade 1–4 wounds and pressure ulcers in SCI patients achieved stable closure with MPPT treatment.
- 2MPPT reduced soft tissue infection in wounds acting as draining fistulas from osteomyelitis and supported tissue regeneration, considerably reducing fistula sizes.
- 3The telemedicine approach for delivering MPPT was well-received and supported independence and self-care among participants.
Research Summary
Practical Implications
Clinical Practice
MPPT offers a safe and effective alternative to traditional antimicrobial treatments for wound care, especially in immunocompromised patients, reducing the risk of antimicrobial resistance.
Healthcare Economics
Implementing MPPT can lead to substantial cost savings for healthcare systems by reducing treatment duration, nursing requirements, and the need for expensive antimicrobial agents.
Patient Care
Telemedicine-based MPPT treatment enhances patient independence and self-care, improving quality of life and satisfaction with wound management.
Study Limitations
- 1Single-arm study design limits internal comparators.
- 2Pressure ulcers in SCI persons are an orphan indication, impacting recruitment rate.
- 3Cost comparisons are limited by the inclusion of non-SCI patients in external comparator data.